Strengthening and Modernizing Biosafety Oversight: Region 1 Listening Session

NIH Videocast

https://videocast.nih.gov/watch=57067

Agenda

Meeting Flyer

Introductory Slides

Public Comments

NIH and its partners encourage any interested individual to sign up to provide oral comments during the listening session. All comments offered at the listening session are welcome and will be considered, and feedback on the following topics are particularly encouraged.

1. NIH is interested in hearing individual opinions regarding an appropriate scope for its biosafety policy. As a starting point, NIH is interested in hearing feedback on these potential options:

• Current scope of recombinant or synthetic nucleic acids plus research with other biohazards to possibly include wild type biological agents, proteins (e.g., toxins, prions), etc.
• Research with infectious microbes and hazardous biological materials
• Life sciences research

NIH welcomes individuals to offer additional options for the scope of the policy, as well.

1. NIH is equally interested in hearing individual opinions on the types of research that may require less local or NIH oversight based on accrued safety data or due to oversight by other federal authorities. Examples of this type of research may include:

• Non-biomedical research with plants, agricultural animals, or certain microbes under the purview of other federal agencies such as USDA or EPA
• Clinical research under the purview of the FDA
• Other research that, based on accrued safety data, may be low risk (e.g., RG1 agents, some transgenic organisms, some expression plasmids)

NIH welcomes individuals to offer additional examples of research that may require less oversight, as well.

Close

Recent Events